Developer docs
API playgroundTry for free, no card

Search company profiles

SecurMed UK

Full company profile

uuid003h5r3

Namestring
SecurMed UK
Legal namestring
SecurMed UK
Websiteurl
securmed.org.uk
Company typeenum
Private
Founded yearint
2019
Descriptiontext

SecurMed UK is a non-profit organisation designated under the European Falsified Medicines Directive (2011/62/EU) and Delegated Regulation 2016/161 to operate the UKNI Medicines Verification System (UK MVS). The company was established in 2019 (with founding activities dating to 2016) and is registered in England under company number 10276927, with primary offices in Abingdon and Belfast. Its core product is the UKNI MVS, a digital verification platform that allows pharmacies, hospitals, wholesalers and GP practices to verify unique identifiers on prescription medicine packs against national and European repositories, and to decommission packs upon patient supply. The platform is connected to the European Medicines Verification System (EMVS) European Hub, enabling cross-border medicines verification across the UK and Northern Ireland supply chain.

The technical infrastructure is delivered in partnership with Arvato Systems, which provides the IT Solutions Developers Toolkit (SDK), sandbox environment and technical helpdesk for the 42+ approved IT software suppliers building integrations to the system. Supporting capabilities include an Alert Management System (NMVS Alerts AMS) for investigating verification failures, Scanner Check Packs for equipment validation, digital certificate management for secure access, and web-service APIs documented through the Arvato SDK portal.

SecurMed UK earns revenue exclusively from Marketing Authorisation Holders (MAHs) under a mandatory fee structure: a one-time £35,000 set-up fee and a £20,000 annual operational fee per MAH legal entity, with micro-MAH waivers available. End-user organisations (pharmacies, hospitals, GPs, wholesalers) access the system at no charge through certified software providers. The business is governed under oversight from the MHRA and DHSC, with industry partnerships across ABPI, BGMA, HDA UK, and technology partnerships with Arvato Systems, Solidsoft Reply, and the European Medicines Verification Organisation (EMVO).

Short descriptiontext

SecurMed UK operates the UKNI Medicines Verification System, a non-profit digital platform designated under the Falsified Medicines Directive to verify prescription medicines authenticity for UK and Northern Ireland pharmacies, hospitals, wholesalers and GPs, funded by pharmaceutical manufacturers through mandatory MAH fees.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersAbingdon, United Kingdom
HQ citystring
Abingdon
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medicines verification system, falsified medicines directive, pharmaceutical supply chain, prescription authentication platform, drug serialization verification
Industry1 code
1ePrescribing & Medication Workflow Platforms (EPCS, formulary, prior auth, med history)
CodeHLALAIADPrimaryYes
NAICS code1 code
  • Medical and Diagnostic Laboratories6215
SIC code1 code
  • Services-Health Services8000
Product category
Pharmaceutical Medicines Verification
Social media profiles1 record
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model3 records
1MAH Set-Up Fees
TypeOne Time License
Description

One-time set-up fee of GBP £35,000 payable upon MAH registration. Each MAH legal entity must pay separately, so companies with multiple MAH entities pay fees for each.

securmed.org.uk
2Annual MAH Operational Fees
TypeSubscription Recurring
Description

Annual operational fee of GBP £20,000 for 2019 (likely adjusted for subsequent years) payable by each MAH legal entity. Payment required within 30 days of invoice.

securmed.org.uk
3End User Access (No Cost)
TypeSubscription Recurring
Description

No fees charged to end users (pharmacies, hospitals, wholesalers, GPs). The system is funded entirely by pharmaceutical manufacturers and parallel distributors (MAHs), as mandated under the Falsified Medicines Directive.

securmed.org.uk
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Operations, Personnel, Marketing or Sales, Others
Pricing details4 tiers
1MAH Set-Up Fee
ModelOne time/ perpetual licenseBilling cadenceMulti-year contract
Notes

GBP £35,000 payable upon registration. Each MAH legal entity active in the UK must pay this fee separately.

securmed.org.uk
2Annual MAH Operational Fee
ModelSubscriptionBilling cadenceAnnual
Notes

GBP £20,000 per year (2019 rate). Each MAH legal entity pays separately.

securmed.org.uk
3Micro MAH Fee Waiver
ModelSubscriptionBilling cadenceAnnual
Notes

Fee waiver for micro MAH entities that can demonstrate eligibility. Details in Micro MAH Fee Waiver document.

securmed.org.uk
4End User Access
ModelFreemiumBilling cadenceAnnual
Notes

No charge for end users (pharmacies, hospitals, wholesalers, GP practices). System funded by MAH fees.

securmed.org.uk
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

SecurMed UK operates the UKNI Medicines Verification System (UK MVS), a national digital verification platform that authenticates prescription medicine packs against the European Medicines Verification System to prevent falsified medicines from entering the UK supply chain. The service is delivered to Marketing Authorisation Holders (MAHs), pharmacies, hospitals, wholesalers, and GP practices, with end users accessing verification and decommissioning capabilities through approved IT software suppliers integrated via the Arvato Systems SDK.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Connected to European Hub (EMVS) since 31st October 2018
Product overview1 text field

SecurMed UK operates the UKNI Medicines Verification System (UK MVS) — a core platform for verifying prescription medicines under the Falsified Medicines Directive. The system consists of the main UKNI MVS platform for medicine verification and decommissioning, supplemented by the NMVS Alerts AMS for alert management, Scanner Check Packs for equipment verification, and digital certificate management for secure access. The IT Solutions Developers Toolkit (SDK) enables third-party software providers to build integrations with the UK MVS. End users (pharmacies, hospitals, GPs, wholesalers) and Marketing Authorisation Holders (MAHs) register through separate portals and pay applicable fees (Set-Up Fee of £35,000 and Annual Operational Fee of £20,000 for MAHs).

Product and service6 records
1UKNI Medicines Verification System (UK MVS)
CategoryCore verification platform
Description

The core national medicines verification system for the UK that enables verification and authentication of prescription medicines against falsification, as required under the Falsified Medicines Directive. The system verifies unique identifiers on medicine packs and manages decommissioning at the point of supply to patients. It is used by MAHs to upload pack data, and by pharmacies, hospitals, wholesalers and GPs to verify medicines.

2NMVS Alerts AMS (Alert Management System)
CategoryAlert management sub-product
Description

Alert Management System for the NMVS that enables stakeholders to manage, investigate, and report alerts when medicines verification fails or suspicious products are detected. Used by end users and MAHs to progress the analysis of alerts generated by the UK MVS.

3Scanner Check Packs
CategoryEnd-user verification tool
Description

Verification tool allowing end users to test their scanner and software configuration against the UK MVS to ensure proper setup before scanning actual medicine packs. Used by end-user organisations during onboarding and configuration validation.

4UKNI MVS Digital Certificates
CategorySecure access credentials
Description

Digital certificates with 2-year validity required for accessing the UKNI MVS. Users receive system-generated reminders at 60 days and 30 days before expiry and must download new certificates via the Certificate Portal. Required by all end users to authenticate system access.

5End User Registration System
CategoryOnboarding service
Description

Registration process and portal for organisations that handle or dispense prescription medicines in Northern Ireland, including Community Pharmacies, Hospital Pharmacies, GP Practices, Wholesalers, and Healthcare Institutions. Required to obtain access to the UKNI MVS.

6IT Solutions Developers Toolkit (SDK)
CategoryDeveloper integration platform
Description

Software development toolkit provided by Arvato Systems that enables IT software providers to create web-services interface connections to the UK MVS. The SDK includes technical documentation, a sandbox test environment with test serial number creation, sample code snippets, test plans and reports, a pre-release baseline testing procedure, and a technical helpdesk service. Used by approved software suppliers.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership9 partners
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2018-10-31
Description

Arvato Systems is the IT Service Provider for the UK Medicines Verification System, providing the technical infrastructure, Developers Toolkit (SDK), sandbox environment, and technical helpdesk services for software suppliers connecting to the UK MVS.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2018-10-31
Description

SecurMed UK is connected to the European Hub operated by EMVO, enabling UK pharmacies, hospitals, and wholesalers to verify medicines against the pan-European EMVS database.

Strategic tierCoreTypeOthers
Description

MHRA is the UK competent authority that designated SecurMed UK to operate the UKNI MVS and provides guidance on FMD implementation and compliance.

Strategic tierCoreTypeOthers
Description

DHSC, along with MHRA, confirmed FMD requirements for the UK and designated SecurMed UK as the UKNI Medicines Verification Organisation.

Strategic tierSupportingTypeStrategic or Co-development Partner
Description

NHS Digital developed guidance toolkits for healthcare professionals implementing FMD, including GP Practice toolkit and falsified medicines implementation resources.

Strategic tierSupportingTypeStrategic or Co-development Partner
Description

Industry association providing guidance for manufacturers and MAHs on FMD compliance.

Strategic tierSupportingTypeStrategic or Co-development Partner
Description

Industry association representing generic medicine manufacturers in the UK.

Strategic tierSupportingTypeStrategic or Co-development Partner
Description

Industry association providing guidance for wholesalers on FMD compliance.

Strategic tierSupportingTypeTechnology or Integration
Description

Provides the EU Hub infrastructure. Live status of all Solidsoft Reply Countries available at status.nmvo.eu.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Market position
Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
Yes

Docs URL, Description

Integration48 records

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

SecurMed UK

Pharmaceutical Medicines Verificationsecurmed.org.uk

SecurMed UK operates the UKNI Medicines Verification System, a non-profit digital platform designated under the Falsified Medicines Directive to verify prescription medicines authenticity for UK and Northern Ireland pharmacies, hospitals, wholesalers and GPs, funded by pharmaceutical manufacturers through mandatory MAH fees.

What SecurMed UK does

SecurMed UK is a non-profit organisation designated under the European Falsified Medicines Directive (2011/62/EU) and Delegated Regulation 2016/161 to operate the UKNI Medicines Verification System (UK MVS). The company was established in 2019 (with founding activities dating to 2016) and is registered in England under company number 10276927, with primary offices in Abingdon and Belfast. Its core product is the UKNI MVS, a digital verification platform that allows pharmacies, hospitals, wholesalers and GP practices to verify unique identifiers on prescription medicine packs against national and European repositories, and to decommission packs upon patient supply. The platform is connected to the European Medicines Verification System (EMVS) European Hub, enabling cross-border medicines verification across the UK and Northern Ireland supply chain.

The technical infrastructure is delivered in partnership with Arvato Systems, which provides the IT Solutions Developers Toolkit (SDK), sandbox environment and technical helpdesk for the 42+ approved IT software suppliers building integrations to the system. Supporting capabilities include an Alert Management System (NMVS Alerts AMS) for investigating verification failures, Scanner Check Packs for equipment validation, digital certificate management for secure access, and web-service APIs documented through the Arvato SDK portal.

SecurMed UK earns revenue exclusively from Marketing Authorisation Holders (MAHs) under a mandatory fee structure: a one-time £35,000 set-up fee and a £20,000 annual operational fee per MAH legal entity, with micro-MAH waivers available. End-user organisations (pharmacies, hospitals, GPs, wholesalers) access the system at no charge through certified software providers. The business is governed under oversight from the MHRA and DHSC, with industry partnerships across ABPI, BGMA, HDA UK, and technology partnerships with Arvato Systems, Solidsoft Reply, and the European Medicines Verification Organisation (EMVO).

SecurMed UK firmographics

Firmographics
Name
SecurMed UK
Legal name
SecurMed UK
Website
https://securmed.org.uk
Company type
Private
Founded year
2019
Operating status
Operating
Headcount range
1–10 employees
Short description
SecurMed UK operates the UKNI Medicines Verification System, a non-profit digital platform designated under the Falsified Medicines Directive to verify prescription medicines authenticity for UK and Northern Ireland pharmacies, hospitals, wholesalers and GPs, funded by pharmaceutical manufacturers through mandatory MAH fees.
Ownership category
akta.pro rank

SecurMed UK industry classification

Industry
Product category
Pharmaceutical Medicines Verification
NAICS
Medical and Diagnostic Laboratories (6215)
SIC
Services-Health Services (8000)
akta.pro primary industry
ePrescribing & Medication Workflow Platforms (EPCS, formulary, prior auth, med history) (HLALAIAD)

Keywords

  • Medicines verification system
  • Falsified medicines directive
  • Pharmaceutical supply chain
  • Prescription authentication platform
  • Drug serialization verification

Where SecurMed UK is headquartered

Location

Headquarters

HQ city
Abingdon
HQ country
United Kingdom
HQ region
Europe

Offices2 records

Markets served

SecurMed UK business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Operations, Personnel, Marketing or Sales, Others

Revenue model

  1. MAH Set-Up Fees: One-time set-up fee of GBP £35,000 payable upon MAH registration. Each MAH legal entity must pay separately, so companies with multiple MAH entities pay fees for each.
  2. Annual MAH Operational Fees: Annual operational fee of GBP £20,000 for 2019 (likely adjusted for subsequent years) payable by each MAH legal entity. Payment required within 30 days of invoice.
  3. End User Access (No Cost): No fees charged to end users (pharmacies, hospitals, wholesalers, GPs). The system is funded entirely by pharmaceutical manufacturers and parallel distributors (MAHs), as mandated under the Falsified Medicines Directive.

Pricing tiers

ModelBillingPrice
One time/ perpetual licenseMulti-year contractMAH Set-Up Fee
SubscriptionAnnualAnnual MAH Operational Fee
SubscriptionAnnualMicro MAH Fee Waiver
FreemiumAnnualEnd User Access

Go-to-market motion3 records

Distribution channels3 records

Marketing channels4 records

SecurMed UK product offering

Product offering

Core offering

SecurMed UK operates the UKNI Medicines Verification System (UK MVS), a national digital verification platform that authenticates prescription medicine packs against the European Medicines Verification System to prevent falsified medicines from entering the UK supply chain. The service is delivered to Marketing Authorisation Holders (MAHs), pharmacies, hospitals, wholesalers, and GP practices, with end users accessing verification and decommissioning capabilities through approved IT software suppliers integrated via the Arvato Systems SDK.

Product overview

SecurMed UK operates the UKNI Medicines Verification System (UK MVS) — a core platform for verifying prescription medicines under the Falsified Medicines Directive. The system consists of the main UKNI MVS platform for medicine verification and decommissioning, supplemented by the NMVS Alerts AMS for alert management, Scanner Check Packs for equipment verification, and digital certificate management for secure access. The IT Solutions Developers Toolkit (SDK) enables third-party software providers to build integrations with the UK MVS. End users (pharmacies, hospitals, GPs, wholesalers) and Marketing Authorisation Holders (MAHs) register through separate portals and pay applicable fees (Set-Up Fee of £35,000 and Annual Operational Fee of £20,000 for MAHs).

Differentiator

Problem solved

Functional benefit

Products and services

  • UKNI Medicines Verification System (UK MVS) The core national medicines verification system for the UK that enables verification and authentication of prescription medicines against falsification, as required under the Falsified Medicines Directive. The system verifies unique identifiers on medicine packs and manages decommissioning at the point of supply to patients. It is used by MAHs to upload pack data, and by pharmacies, hospitals, wholesalers and GPs to verify medicines.
  • NMVS Alerts AMS (Alert Management System) Alert Management System for the NMVS that enables stakeholders to manage, investigate, and report alerts when medicines verification fails or suspicious products are detected. Used by end users and MAHs to progress the analysis of alerts generated by the UK MVS.
  • Scanner Check Packs Verification tool allowing end users to test their scanner and software configuration against the UK MVS to ensure proper setup before scanning actual medicine packs. Used by end-user organisations during onboarding and configuration validation.
  • UKNI MVS Digital Certificates Digital certificates with 2-year validity required for accessing the UKNI MVS. Users receive system-generated reminders at 60 days and 30 days before expiry and must download new certificates via the Certificate Portal. Required by all end users to authenticate system access.
  • End User Registration System Registration process and portal for organisations that handle or dispense prescription medicines in Northern Ireland, including Community Pharmacies, Hospital Pharmacies, GP Practices, Wholesalers, and Healthcare Institutions. Required to obtain access to the UKNI MVS.
  • IT Solutions Developers Toolkit (SDK) Software development toolkit provided by Arvato Systems that enables IT software providers to create web-services interface connections to the UK MVS. The SDK includes technical documentation, a sandbox test environment with test serial number creation, sample code snippets, test plans and reports, a pre-release baseline testing procedure, and a technical helpdesk service. Used by approved software suppliers.

Quantifiable outcome

  • Connected to European Hub (EMVS) since 31st October 2018

Companies that use SecurMed UK

Customer profile

Named customers4 records

Segments3 records

Ideal customer profiles3 records

SecurMed UK technology and API

Technology

Technology focussed Yes

API detail

Has API
Yes
API docs
API detail

Core technology

AI maturity

App detail

Integration48 records

Feature4 records

SecurMed UK partnerships and signals

Strategic signal

Partnerships

Nine partnerships are on record, tiered core and supporting.

  • Arvato SystemscoreTechnology or Integration · 31 October 2018Arvato Systems is the IT Service Provider for the UK Medicines Verification System, providing the technical infrastructure, Developers Toolkit (SDK), sandbox environment, and technical helpdesk services for software suppliers connecting to the UK MVS.
  • European Medicines Verification Organisation (EMVO)coreTechnology or Integration · 31 October 2018SecurMed UK is connected to the European Hub operated by EMVO, enabling UK pharmacies, hospitals, and wholesalers to verify medicines against the pan-European EMVS database.
  • Medicines and Healthcare products Regulatory Agency (MHRA)coreOthersMHRA is the UK competent authority that designated SecurMed UK to operate the UKNI MVS and provides guidance on FMD implementation and compliance.
  • Department of Health and Social Care (DHSC)coreOthersDHSC, along with MHRA, confirmed FMD requirements for the UK and designated SecurMed UK as the UKNI Medicines Verification Organisation.
  • NHS DigitalsupportingStrategic or Co-development PartnerNHS Digital developed guidance toolkits for healthcare professionals implementing FMD, including GP Practice toolkit and falsified medicines implementation resources.
  • ABPI (Association of the British Pharmaceutical Industry)supportingStrategic or Co-development PartnerIndustry association providing guidance for manufacturers and MAHs on FMD compliance.
  • BGMA (British Generic Manufacturers Association)supportingStrategic or Co-development PartnerIndustry association representing generic medicine manufacturers in the UK.
  • HDA UK (Healthcare Distribution Association)supportingStrategic or Co-development PartnerIndustry association providing guidance for wholesalers on FMD compliance.
  • Solidsoft ReplysupportingTechnology or IntegrationProvides the EU Hub infrastructure. Live status of all Solidsoft Reply Countries available at status.nmvo.eu.

Scale indicators3 records

Recent moves6 records

Expansion highlights4 records

SecurMed UK competitors and assessment

Company assessment

Market position

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

SecurMed UK social profiles

Digital presence

SecurMed UK compliance and trust

Trust signal

Compliance2 records

SecurMed UK financial estimates

Financial estimate

Revenue estimate

Valuation estimate

SecurMed UK leadership team

Management profile

Number of profiles

SecurMed UK funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

SecurMed UK M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SecurMed UK

What does SecurMed UK do?

SecurMed UK operates the UKNI Medicines Verification System (UK MVS), a national digital verification platform that authenticates prescription medicine packs against the European Medicines Verification System to prevent falsified medicines from entering the UK supply chain. The service is delivered to Marketing Authorisation Holders (MAHs), pharmacies, hospitals, wholesalers, and GP practices, with end users accessing verification and decommissioning capabilities through approved IT software suppliers integrated via the Arvato Systems SDK.

Is SecurMed UK a public or private company?

SecurMed UK is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was SecurMed UK founded?

SecurMed UK was founded in 2019. It employs 1 to 10 people.

Where is SecurMed UK based?

SecurMed UK is headquartered in Abingdon, United Kingdom, in the Europe region.

How does SecurMed UK make money?

Three revenue lines are on record. MAH Set-Up Fees are the primary driver. The others are annual MAH Operational Fees and end User Access (No Cost).

Does SecurMed UK have an API?

Yes. SecurMed UK, through IT Service Provider Arvato Systems, provides an IT Solutions Developers Toolkit (SDK) to IT software providers and departments to enable them to create interface (web-services) connections to the UK MVS. The SDK contains a full set of technical documentation, a Sandbox test environment with test serial number creation, sample code snippets, test plans and reports, a pre-release baseline testing procedure, and a technical helpdesk service. Software suppliers can register for the SDK at https://sws-nmvs.eu. Developer documentation is at sws-nmvs.eu.

What industry is SecurMed UK in?

SecurMed UK's product category is Pharmaceutical Medicines Verification. Its primary akta.pro industry code is HLALAIAD, ePrescribing & Medication Workflow Platforms (EPCS, formulary, prior auth, med history). Its NAICS code is 6215 and its SIC code is 8000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales